Search research articles
Contact Us
Filters
Showing results (51-60 of 85) with videos related to
Page
of 9
Sort By:
Acta Oto-Laryngologica. Supplementum
|
January 1, 1988
Bacterial adherence and upper respiratory tract disease: a correlation between S. pyogenes attachment and recurrent throat infections
G B Galioto, E Mevio, R Maserati, et al.
Antiviral Therapy
|
March 7, 2002
Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz
F Maggiolo, M Migliorino, R Maserati, et al.
Journal of Chemotherapy (Florence, Italy)
|
January 5, 2002
Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profile
M B Regazzi, E Seminari, P Villani, et al.
Antiviral Research
|
May 16, 2000
Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART
S Paolucci, F Baldanti, R Maserati, et al.
The Journal of Infectious Diseases
|
November 1, 1994
Effectiveness of aminosidine (paromomycin) sulfate in chronic Cryptosporidium diarrhea in AIDS patients: an open, uncontrolled, prospective clinical trial
M Scaglia, C Atzori, G Marchetti, et al.
Journal of Neurovirology
|
August 25, 2001
Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients
P Ferrante, M Mediati, R Caldarelli-Stefano, et al.
Journal of Medical Virology
|
July 1, 1997
Comprehensive investigation of the presence of JC virus in AIDS patients with and without progressive multifocal leukoencephalopathy
P Ferrante, R Caldarelli-Stefano, E Omodeo-Zorini, et al.
The Journal of Antimicrobial Chemotherapy
|
March 7, 2000
Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients
M B Regazzi, P Villani, R Maserati, et al.
Therapeutic Drug Monitoring
|
June 12, 1999
High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma
P Villani, M Pregnolato, S Banfo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 20, 2011
A new approach to safely type for HLA the HIV infected people eligible to abacavir therapy: saliva or buccal swab as reliable DNA sources
C Badulli, I Sbarsi, D Di Giorgio, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 85) with videos related to
Sort By:
Page
of 9
Acta Oto-Laryngologica. Supplementum
|
January 1, 1988
Bacterial adherence and upper respiratory tract disease: a correlation between S. pyogenes attachment and recurrent throat infections
G B Galioto, E Mevio, R Maserati, et al.
Antiviral Therapy
|
March 7, 2002
Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz
F Maggiolo, M Migliorino, R Maserati, et al.
Journal of Chemotherapy (Florence, Italy)
|
January 5, 2002
Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profile
M B Regazzi, E Seminari, P Villani, et al.
Antiviral Research
|
May 16, 2000
Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART
S Paolucci, F Baldanti, R Maserati, et al.
The Journal of Infectious Diseases
|
November 1, 1994
Effectiveness of aminosidine (paromomycin) sulfate in chronic Cryptosporidium diarrhea in AIDS patients: an open, uncontrolled, prospective clinical trial
M Scaglia, C Atzori, G Marchetti, et al.
Journal of Neurovirology
|
August 25, 2001
Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients
P Ferrante, M Mediati, R Caldarelli-Stefano, et al.
Journal of Medical Virology
|
July 1, 1997
Comprehensive investigation of the presence of JC virus in AIDS patients with and without progressive multifocal leukoencephalopathy
P Ferrante, R Caldarelli-Stefano, E Omodeo-Zorini, et al.
The Journal of Antimicrobial Chemotherapy
|
March 7, 2000
Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients
M B Regazzi, P Villani, R Maserati, et al.
Therapeutic Drug Monitoring
|
June 12, 1999
High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma
P Villani, M Pregnolato, S Banfo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 20, 2011
A new approach to safely type for HLA the HIV infected people eligible to abacavir therapy: saliva or buccal swab as reliable DNA sources
C Badulli, I Sbarsi, D Di Giorgio, et al.
Page
of 9